Extra control lysate for the AlphaLISA™ SureFire® Ultra™ Human Total WDR5 assay. This control is already provided in the AlphaLISA SureFire Ultra Human Total WDR5 assay kit, but can also be ordered separately.
For research use only. Not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Extra control lysate for the AlphaLISA™ SureFire® Ultra™ Human Total WDR5 assay. This control is already provided in the AlphaLISA SureFire Ultra Human Total WDR5 assay kit, but can also be ordered separately.
For research use only. Not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption, and disposal requirements under European REACH regulations (EC 1907/2006).
This control lysate is intended for use with the AlphaLISA SureFire Ultra Human Total WDR5 Detection Kit or for use as a control for those running orthogonal or secondary assays along with the SureFire assay. To prepare the lysate, Jurkat cells were cultured in T175 flasks to 1 x 106 cells/mL in medium containing 10% FBS and lysed at 3.2 x 106 cells/mL with SureFire Ultra Lysis Buffer.
Application |
Cell Signaling
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA SureFire Ultra
|
Detection Modality |
Alpha
|
Lysis Buffer Compatibility |
Lysis Buffer B
|
Molecular Modification |
Total
|
Product Group |
Control Lysate
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
WDR5
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
Alpha
|
Therapeutic Area |
Oncology
|
Unit Size |
1 Vial
|
Are you looking for resources, click on the resource type to explore further.
Discover Alpha SureFire® Ultra™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology...
We are here to answer your questions.